Sotera Health (NASDAQ:SHC) Shares Acquired by Geode Capital Management LLC

Geode Capital Management LLC lifted its holdings in shares of Sotera Health (NASDAQ:SHC - Free Report) by 19.4% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 2,755,391 shares of the company's stock after acquiring an additional 447,186 shares during the period. Geode Capital Management LLC owned approximately 0.97% of Sotera Health worth $46,026,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Bank of New York Mellon Corp lifted its position in Sotera Health by 3.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,004,046 shares of the company's stock worth $11,918,000 after acquiring an additional 37,681 shares during the period. TD Asset Management Inc increased its holdings in Sotera Health by 1.5% in the second quarter. TD Asset Management Inc now owns 123,454 shares of the company's stock valued at $1,465,000 after buying an additional 1,800 shares in the last quarter. First Pacific Advisors LP acquired a new position in Sotera Health in the 2nd quarter worth about $540,000. Victory Capital Management Inc. lifted its position in shares of Sotera Health by 25.4% during the 2nd quarter. Victory Capital Management Inc. now owns 25,944 shares of the company's stock valued at $308,000 after buying an additional 5,258 shares in the last quarter. Finally, Arizona State Retirement System raised its position in Sotera Health by 45.6% during the second quarter. Arizona State Retirement System now owns 39,589 shares of the company's stock worth $470,000 after acquiring an additional 12,404 shares during the period. Institutional investors and hedge funds own 91.03% of the company's stock.

Sotera Health Stock Up 1.7 %

Shares of SHC traded up $0.22 during mid-day trading on Tuesday, reaching $13.55. The company's stock had a trading volume of 497,699 shares, compared to its average volume of 1,338,186. The company's 50 day moving average is $14.35 and its 200 day moving average is $14.25. The stock has a market cap of $3.84 billion, a PE ratio of 54.20 and a beta of 1.96. Sotera Health has a 12-month low of $10.71 and a 12-month high of $17.44. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The firm had revenue of $285.47 million for the quarter, compared to analysts' expectations of $278.64 million. During the same period in the previous year, the business posted $0.18 EPS. The business's revenue for the quarter was up 8.5% compared to the same quarter last year. Equities analysts anticipate that Sotera Health will post 0.61 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have issued reports on SHC. Citigroup lifted their target price on shares of Sotera Health from $18.00 to $20.00 and gave the stock a "buy" rating in a research note on Wednesday, November 6th. Royal Bank of Canada reiterated an "outperform" rating and issued a $17.00 price objective on shares of Sotera Health in a research report on Thursday, November 21st. Finally, The Goldman Sachs Group initiated coverage on Sotera Health in a research note on Friday, December 6th. They issued a "neutral" rating and a $14.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $16.08.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.